CXHL1900207 | 马来酸吡咯替尼片 | pyrotinib maleate | Tablet | Chemical Drugs(2.4) | New Drug Application | 2019-06-24 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | In Review | 2019-06-21 | view |
CXHB2200193 | 马来酸吡咯替尼片 | pyrotinib maleate | Tablet | Chemical Drugs(1) | Supplementary Application | 2022-11-16 | | Jiangsu Hengrui Pharmaceuticals Co Ltd | | | view |
CXHB2000015 | 马来酸吡咯替尼片 | pyrotinib maleate | Tablet | Chemical Drugs | Supplementary Application | 2020-03-17 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd;Shanghai Hengrui Pharmaceutical Co Ltd | In Review | 2020-03-16 | view |
CXHB1500038 | 马来酸吡咯替尼片 | pyrotinib maleate | Tablet | Chemical Drugs | Supplementary Application | 2015-05-25 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd;Shanghai Hengrui Pharmaceutical Co Ltd | Certificate Issued | 2016-03-17 | view |
CXHB2000096 | 马来酸吡咯替尼片 | pyrotinib maleate | Tablet | Chemical Drugs(2.4) | Supplementary Application | 2020-09-30 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | In Review | 2020-09-30 | view |
CXHS1700014 | 马来酸吡咯替尼片 | pyrotinib maleate | Tablet | Chemical Drugs(1) | New Drug Application | 2017-08-24 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd;Shanghai Hengrui Pharmaceutical Co Ltd | Certificate Issued | 2018-08-17 | view |
CXHB2101073 | 马来酸吡咯替尼片 | pyrotinib maleate | Tablet | Chemical Drugs | Supplementary Application | 2021-07-30 | | Jiangsu Hengrui Pharmaceuticals Co Ltd | | | view |
CXHL1900299 | 马来酸吡咯替尼片 | pyrotinib maleate | Tablet | Chemical Drugs(2.4) | New Drug Application | 2019-09-19 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | In Review | 2019-09-18 | view |
CXHL1100290 | 马来酸吡咯替尼片 | pyrotinib maleate | Tablet | Chemical Drugs(1.1) | New Drug Application | 2011-05-27 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | Certificate Issued | 2012-05-23 | view |
CXHL2300388 | 马来酸吡咯替尼片 | pyrotinib maleate | Tablet | Chemical Drugs(2.4) | New Drug Application | 2023-04-18 | | Jiangsu Hengrui Pharmaceuticals Co Ltd | | | view |
CXHL2000310 | 马来酸吡咯替尼片 | pyrotinib maleate | Tablet | Chemical Drugs(2.4) | New Drug Application | 2020-07-04 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | In Review | 2020-07-02 | view |
CXHB1600050 | 马来酸吡咯替尼片 | pyrotinib maleate | Tablet | Chemical Drugs | Supplementary Application | 2016-09-19 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd;Shanghai Hengrui Pharmaceutical Co Ltd | Certificate Issued | 2017-03-29 | view |
CXHS2101041 | 马来酸吡咯替尼片 | pyrotinib maleate | Tablet | Chemical Drugs(2.4) | New Drug Application | 2021-09-15 | | Jiangsu Hengrui Pharmaceuticals Co Ltd | | | view |
CXHS2200053 | 马来酸吡咯替尼片 | pyrotinib maleate | Tablet | Chemical Drugs(2.4) | New Drug Application | 2022-10-09 | | Jiangsu Hengrui Pharmaceuticals Co Ltd | | | view |
CXHB2000014 | 马来酸吡咯替尼片 | pyrotinib maleate | Tablet | Chemical Drugs | Supplementary Application | 2020-03-17 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd;Shanghai Hengrui Pharmaceutical Co Ltd | In Review | 2020-03-16 | view |
CXHB1500039 | 马来酸吡咯替尼片 | pyrotinib maleate | Tablet | Chemical Drugs | Supplementary Application | 2015-05-25 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd;Shanghai Hengrui Pharmaceutical Co Ltd | Certificate Issued | 2016-03-17 | view |
CXHB2000076 | 马来酸吡咯替尼片 | pyrotinib maleate | Tablet | Chemical Drugs(2.4) | Supplementary Application | 2020-08-27 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | In Review | 2020-08-25 | view |
CXHS1700013 | 马来酸吡咯替尼片 | pyrotinib maleate | Tablet | Chemical Drugs(1) | New Drug Application | 2017-08-24 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd;Shanghai Hengrui Pharmaceutical Co Ltd | Certificate Issued | 2018-08-17 | view |
CXHB2101074 | 马来酸吡咯替尼片 | pyrotinib maleate | Tablet | Chemical Drugs | Supplementary Application | 2021-07-30 | | Jiangsu Hengrui Pharmaceuticals Co Ltd | | | view |
CXHL1900300 | 马来酸吡咯替尼片 | pyrotinib maleate | Tablet | Chemical Drugs(2.4) | New Drug Application | 2019-09-19 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | In Review | 2019-09-18 | view |